NYSE · Healthcare
CVS HEALTH Corp (CVS)
As-reported financials and recent SEC filings for CVS HEALTH Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$402.07B
Net income
$1.77B
Net margin
0.4%
Diluted EPS
$1.39
ROE
2.3%
P/E (TTM)
44.7×
Market cap
$130.09B
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Gross profit | — | — | — | — | — |
| Operating income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| Diluted EPS | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-01
View on EDGAR →42026-06-01
View on EDGAR →1442026-05-22
View on EDGAR →S-82026-05-22
View on EDGAR →S-3ASR2026-05-22
View on EDGAR →42026-05-22
View on EDGAR →1442026-05-21
View on EDGAR →42026-05-21
View on EDGAR →Go deeper on CVS
Search CVS HEALTH Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.